Glimcher Realty Trust
AQR Capital increases stake in Intel
Intel generated ~$5.7 billion in cash from operations. The company paid quarterly dividends of $1.1 billion and repurchased 122 million shares for $4.2 billion.
AQR Capital sold its stake in Riverbed Technology
On October 27, NetApp announced the acquisition of Riverbed’s SteelStore product line in an all-cash transaction for approximately $80 million.
AQR Capital sold its position in AstraZeneca
AstraZeneca is one of a few pure-play bio-pharmaceutical companies that span a medicine’s entire value chain.
AQR Capital ups position in Glimcher Realty Trust
Glimcher Realty Trust is one of the leading real estate investment trusts or REITs. It owns, manages, and develops a portfolio of retail properties.
AQR Capital ups position in Shire Plc
AQR Capital increased its position in Shire Plc during the third quarter of 2014. The stock accounts for 0.58% of the total portfolio.
AQR Capital raises position in Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative medicines for life-threatening illnesses around the world.